Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Cti biopharma corp. symbols : NVS save search
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: -0.95%
H: 1.05%
C: 0.54%
ADCT | $4.91 4.92% 150K
|
Health Technology
|
| O: -0.81%
H: 3.48%
C: -0.82%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: -1.09%
H: 1.45%
C: 1.24%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -2.22%
AMGN | News | $273.19 0.47% 360K
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
global therapeutics market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published: 2023-03-10 (Crawled : 23:00) - prnewswire.com
AMGN | News | $273.19 0.47% 360K
|
Health Technology
| Email alert
Add to watchlist
CTIC | $9.09 0.05% 11M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 630
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.995 1.0% 590K
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.91 4.92% 150K
|
Health Technology
| Email alert
Add to watchlist
approval therapeutics growth market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.91 4.92% 150K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | News | $273.19 0.47% 360K
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: -1.17%
H: 0.68%
C: 0.68%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: -0.22%
H: 2.4%
C: 1.27%
GLPG | News | $29.575 1.74% 49K
|
Health Technology
|
| O: -2.66%
H: 0.35%
C: -1.83%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 6.03%
H: 13.88%
C: 12.71%
AZN | News | $70.54 0.59% 1.7M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
growth
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021-2026: Ballooning Elderly Population - The Vital Growth Driver for AML Therapeutics
Published: 2021-12-06 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.75 200
|
Health Technology
|
| O: -1.49%
H: 1.45%
C: 0.92%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 2.02%
H: 0.04%
C: -0.89%
IMNPQ | $0.001
|
Manufacturing
|
| O: 50.0%
H: 0.0%
C: -33.33%
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: -3.39%
H: 3.45%
C: 3.3%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
MEIP | $3.31 -1.78% 4K
|
Health Technology
|
| O: -4.4%
H: 0.0%
C: 0.0%
JAZZ | $110.11 1.18% 80K
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
CYCC | $1.72 -1.71% 11K
|
Health Technology
|
| O: -5.93%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 7.24%
H: 0.0%
C: 0.0%
AMGN | News | $273.19 0.47% 360K
|
Health Technology
|
| O: 2.53%
H: 0.0%
C: 0.0%
AGIO | $31.645 4.75% 350K
|
Health Technology
|
| O: -5.47%
H: 0.0%
C: 0.0%
myeloid leukemia leukemia therapeutics growth acute myeloid leukemia aml
Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach $976.2 Billion by 2026
Published: 2021-08-11 (Crawled : 12:00) - prnewswire.com
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.51%
H: 0.13%
C: -0.27%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.3%
H: 0.16%
C: -1.25%
MEIP | $3.31 -1.78% 4K
|
Health Technology
|
| O: 0.37%
H: 0.36%
C: 0.0%
JAZZ | $110.11 1.18% 80K
|
Health Technology
|
| O: -0.09%
H: 1.32%
C: 0.35%
CYCC | $1.72 -1.71% 11K
|
Health Technology
|
| O: -0.19%
H: 0.19%
C: -0.76%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 1.73%
H: 0.34%
C: -7.14%
AMGN | News | $273.19 0.47% 360K
|
Health Technology
|
| O: 0.52%
H: 0.38%
C: -0.44%
AGIO | $31.645 4.75% 350K
|
Health Technology
|
| O: 0.07%
H: 1.52%
C: -0.32%
myeloid leukemia leukemia acute myeloid leukemia aml
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.75 79.52% 1.5M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Your saved searches
Save your searches and get alerts when important news are released.